Treace Medical Concepts
TMCI
118 hedge funds and large institutions have $48.3M invested in Treace Medical Concepts in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 25 closing their positions.
28% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 25
25% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 28
3% more funds holding
Funds holding: 115 → 118 (+3)
0.45% less ownership
Funds ownership: 56.17% → 55.72% (-0.45%)
45% less capital invested
Capital invested by funds: $87.8M → $48.3M (-$39.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$4.17M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.12M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.79M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.22M |
| 5 |
Renaissance Technologies
New York
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Gagnon Advisors
New York
|
-$3.76M |
| 2 |
First Eagle Investment Management
New York
|
-$3.58M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$2.81M |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$708K |
| 5 |
Millennium Management
New York
|
-$707K |
TMCI Hedge Fund Activity: Q1 2026 in Review
118 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2026, worth a combined $48.3M — down 45% from $87.8M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new TMCI positions and 25 closed out — a net gain of 7 holders — while 35 added to existing stakes and 28 trimmed.
The largest buyer was Gagnon Securities, adding an estimated $4.17M. The largest seller was Gagnon Advisors, exiting entirely with an estimated $3.76M sold.
- 118 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2026, up from 115 in Q4 2025.
- Funds reported $48.3M of Treace Medical Concepts stock for Q1 2026, down 45% quarter-over-quarter.
- 32 funds opened new Treace Medical Concepts positions in Q1 2026 and 25 closed out, a net change of +7 holders.
- The largest Treace Medical Concepts buyer in Q1 2026 was Gagnon Securities, an estimated $4.17M added.
- The largest Treace Medical Concepts seller in Q1 2026 was Gagnon Advisors, an estimated $3.76M sold.
Based on aggregated 13F filings for Q1 2026.